Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

Pfizer has bolstered the evidence behind its respiratory syncytial virus (RSV) vaccine with a positive trial of the shot used to protect newborns, adding to earlier results in older adults. The ...

Expectant mothers will have access to free vaccines against respiratory syncytial virus (RSV) from next month under a major ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

Pfizer is looking to follow its vaccine/oral antiviral combination that has proved so profitable in COVID-19 with a similar approach in respiratory syncytial virus (RSV). The drugmaker is in the ...

RSV is a contagious virus causing severe respiratory infections in infants. Vaccination during pregnancy, provides newborns ...

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

will ensure that every single infant in Australia is protected ahead of the winter RSV season.” Women who are 28-36 weeks pregnant will have access to the Pfizer-made Abrysvo vaccine ...